Sanofi Exits FDA Fast-Track Program

Washington — Appointee overruled US drug agency scientists on teplizumab. Acting drug-evaluation director Tracy Beth Høeg rejected staff scientists' positive review; Sanofi exited Commissioner Makary'

STAT